Global AI Drug Repurposing Platform Supply, Demand and Key Producers, 2026-2032
The global AI Drug Repurposing Platform market size is expected to reach $ 6336 million by 2032, rising at a market growth of 23.9% CAGR during the forecast period (2026-2032).
An AI drug repurposing platform is a computational analytics system for approved drugs, clinical-stage assets and shelved compounds. It integrates biomedical knowledge graphs, omics data, clinical trials, real-world data, literature and patent information, and uses machine learning, network medicine, causal inference and large language models to identify new drug-disease links, indication expansion opportunities, combination-therapy leads and translational evidence. It mainly serves pharmaceutical companies, biotechs, research institutes and foundations in pipeline reassessment, rare-disease development and asset rescue, with a blended gross margin of about 65%.
Demand is mainly driven by pharmaceutical cost reduction, redevelopment of existing assets under patent-cliff pressure, rare-disease and niche-indication development, and public-health response scenarios. Compared with de novo drug discovery, repurposing platforms re-rank drug-disease relationships on the basis of existing safety, pharmacokinetic and clinical experience, making them easier to move into proof-of-concept validation, indication expansion and out-licensing discussions.
The supply side is moving from simple literature mining or similarity search toward integrated knowledge graphs, multi-omics, real-world data, clinical-trial data and explainable models. Buyers evaluate not only algorithmic hit rates, but also data coverage, evidence traceability, private-data integration, API or private deployment, security compliance and wet-lab validation capability. Suppliers that combine platform software, expert services and experimental validation loops are better positioned for long-term partnerships.
Regional demand is led by large pharmaceutical companies, biotechs and research foundations in North America and Europe, while Asia-Pacific is benefiting from local innovative-drug pipelines and rising investment in AI-enabled pharma. Key risks include public-data bias, real-world-data compliance, verifiability of predictions and complex commercial rights around candidate drugs, but the return on investment remains attractive for customers with shelved assets, indication-expansion needs and rare-disease programs.
Report Scope
This report studies the global AI Drug Repurposing Platform demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Drug Repurposing Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Drug Repurposing Platform that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Drug Repurposing Platform total market, 2021-2032, (USD Million)
Global AI Drug Repurposing Platform total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Drug Repurposing Platform total market, key domestic companies, and share, (USD Million)
Global AI Drug Repurposing Platform revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Drug Repurposing Platform total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Drug Repurposing Platform total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Drug Repurposing Platform market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BenevolentAI, Healx, Insilico Medicine, Recursion, Lantern Pharma, SOM Biotech, Standigm, Pharos iBio, Aitia, Causaly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Drug Repurposing Platform market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Drug Repurposing Platform Market, By Region:
1. How big is the global AI Drug Repurposing Platform market?
2. What is the demand of the global AI Drug Repurposing Platform market?
3. What is the year over year growth of the global AI Drug Repurposing Platform market?
4. What is the total value of the global AI Drug Repurposing Platform market?
5. Who are the Major Players in the global AI Drug Repurposing Platform market?
6. What are the growth factors driving the market demand?
An AI drug repurposing platform is a computational analytics system for approved drugs, clinical-stage assets and shelved compounds. It integrates biomedical knowledge graphs, omics data, clinical trials, real-world data, literature and patent information, and uses machine learning, network medicine, causal inference and large language models to identify new drug-disease links, indication expansion opportunities, combination-therapy leads and translational evidence. It mainly serves pharmaceutical companies, biotechs, research institutes and foundations in pipeline reassessment, rare-disease development and asset rescue, with a blended gross margin of about 65%.
Demand is mainly driven by pharmaceutical cost reduction, redevelopment of existing assets under patent-cliff pressure, rare-disease and niche-indication development, and public-health response scenarios. Compared with de novo drug discovery, repurposing platforms re-rank drug-disease relationships on the basis of existing safety, pharmacokinetic and clinical experience, making them easier to move into proof-of-concept validation, indication expansion and out-licensing discussions.
The supply side is moving from simple literature mining or similarity search toward integrated knowledge graphs, multi-omics, real-world data, clinical-trial data and explainable models. Buyers evaluate not only algorithmic hit rates, but also data coverage, evidence traceability, private-data integration, API or private deployment, security compliance and wet-lab validation capability. Suppliers that combine platform software, expert services and experimental validation loops are better positioned for long-term partnerships.
Regional demand is led by large pharmaceutical companies, biotechs and research foundations in North America and Europe, while Asia-Pacific is benefiting from local innovative-drug pipelines and rising investment in AI-enabled pharma. Key risks include public-data bias, real-world-data compliance, verifiability of predictions and complex commercial rights around candidate drugs, but the return on investment remains attractive for customers with shelved assets, indication-expansion needs and rare-disease programs.
Report Scope
This report studies the global AI Drug Repurposing Platform demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Drug Repurposing Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Drug Repurposing Platform that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Drug Repurposing Platform total market, 2021-2032, (USD Million)
Global AI Drug Repurposing Platform total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Drug Repurposing Platform total market, key domestic companies, and share, (USD Million)
Global AI Drug Repurposing Platform revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Drug Repurposing Platform total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Drug Repurposing Platform total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Drug Repurposing Platform market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BenevolentAI, Healx, Insilico Medicine, Recursion, Lantern Pharma, SOM Biotech, Standigm, Pharos iBio, Aitia, Causaly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Drug Repurposing Platform market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Drug Repurposing Platform Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Target and Mechanism Mining
- Drug?Disease Matching
- Indication Expansion
- Combination Therapy Prediction
- Evidence Ranking and Validation
- Safety and Translational Assessment
- Biomedical Knowledge Graphs
- Multi-Omics Data
- Clinical and Real-World Data
- Literature and Patent Data
- Chemical and Target Interaction Data
- Integrated Multimodal Data
- Knowledge Graph Reasoning
- Machine Learning Prediction
- Network Medicine Analysis
- Causal Inference Modeling
- Generative and Language Models
- Hybrid Expert-in-the-Loop Models
- SaaS Platform
- Private Deployment
- API and Data Service
- Project-Based Collaboration
- Platform with Wet-Lab Validation
- Rare Disease Repurposing
- Oncology Indication Expansion
- Infectious Disease Response
- CNS and Neurology Research
- Immunology and Inflammation Research
- Asset Rescue and Pipeline Optimization
- BenevolentAI
- Healx
- Insilico Medicine
- Recursion
- Lantern Pharma
- SOM Biotech
- Standigm
- Pharos iBio
- Aitia
- Causaly
1. How big is the global AI Drug Repurposing Platform market?
2. What is the demand of the global AI Drug Repurposing Platform market?
3. What is the year over year growth of the global AI Drug Repurposing Platform market?
4. What is the total value of the global AI Drug Repurposing Platform market?
5. Who are the Major Players in the global AI Drug Repurposing Platform market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI Drug Repurposing Platform Introduction
1.2 World AI Drug Repurposing Platform Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Drug Repurposing Platform Total Market by Region (by Headquarter Location)
1.3.1 World AI Drug Repurposing Platform Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.3 China Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.4 Europe Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.5 Japan Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.6 South Korea Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.8 India Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Drug Repurposing Platform Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Drug Repurposing Platform Consumption Value (2021-2032)
2.2 World AI Drug Repurposing Platform Consumption Value by Region
2.2.1 World AI Drug Repurposing Platform Consumption Value by Region (2021-2026)
2.2.2 World AI Drug Repurposing Platform Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Drug Repurposing Platform Consumption Value (2021-2032)
2.4 China AI Drug Repurposing Platform Consumption Value (2021-2032)
2.5 Europe AI Drug Repurposing Platform Consumption Value (2021-2032)
2.6 Japan AI Drug Repurposing Platform Consumption Value (2021-2032)
2.7 South Korea AI Drug Repurposing Platform Consumption Value (2021-2032)
2.8 ASEAN AI Drug Repurposing Platform Consumption Value (2021-2032)
2.9 India AI Drug Repurposing Platform Consumption Value (2021-2032)
3 WORLD AI DRUG REPURPOSING PLATFORM COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Drug Repurposing Platform Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Drug Repurposing Platform Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Drug Repurposing Platform in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Drug Repurposing Platform in 2025
3.3 AI Drug Repurposing Platform Company Evaluation Quadrant
3.4 AI Drug Repurposing Platform Market: Overall Company Footprint Analysis
3.4.1 AI Drug Repurposing Platform Market: Region Footprint
3.4.2 AI Drug Repurposing Platform Market: Company Product Type Footprint
3.4.3 AI Drug Repurposing Platform Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Drug Repurposing Platform Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Drug Repurposing Platform Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Drug Repurposing Platform Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Drug Repurposing Platform Consumption Value Comparison
4.2.1 United States VS China: AI Drug Repurposing Platform Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Drug Repurposing Platform Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Drug Repurposing Platform Companies and Market Share, 2021-2026
4.3.1 United States Based AI Drug Repurposing Platform Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Drug Repurposing Platform Revenue, (2021-2026)
4.4 China Based Companies AI Drug Repurposing Platform Revenue and Market Share, 2021-2026
4.4.1 China Based AI Drug Repurposing Platform Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Drug Repurposing Platform Revenue, (2021-2026)
4.5 Rest of World Based AI Drug Repurposing Platform Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Drug Repurposing Platform Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Drug Repurposing Platform Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Drug Repurposing Platform Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Target and Mechanism Mining
5.2.2 Drug?Disease Matching
5.2.3 Indication Expansion
5.2.4 Combination Therapy Prediction
5.2.5 Evidence Ranking and Validation
5.2.6 Safety and Translational Assessment
5.3 Market Segment by Type
5.3.1 World AI Drug Repurposing Platform Market Size by Type (2021-2026)
5.3.2 World AI Drug Repurposing Platform Market Size by Type (2027-2032)
5.3.3 World AI Drug Repurposing Platform Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DATA FOUNDATION
6.1 World AI Drug Repurposing Platform Market Size Overview by Data Foundation: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Data Foundation
6.2.1 Biomedical Knowledge Graphs
6.2.2 Multi-Omics Data
6.2.3 Clinical and Real-World Data
6.2.4 Literature and Patent Data
6.2.5 Chemical and Target Interaction Data
6.2.6 Integrated Multimodal Data
6.3 Market Segment by Data Foundation
6.3.1 World AI Drug Repurposing Platform Market Size by Data Foundation (2021-2026)
6.3.2 World AI Drug Repurposing Platform Market Size by Data Foundation (2027-2032)
6.3.3 World AI Drug Repurposing Platform Market Size Market Share by Data Foundation (2027-2032)
7 MARKET ANALYSIS BY ALGORITHMIC METHOD
7.1 World AI Drug Repurposing Platform Market Size Overview by Algorithmic Method: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Algorithmic Method
7.2.1 Knowledge Graph Reasoning
7.2.2 Machine Learning Prediction
7.2.3 Network Medicine Analysis
7.2.4 Causal Inference Modeling
7.2.5 Generative and Language Models
7.2.6 Hybrid Expert-in-the-Loop Models
7.3 Market Segment by Algorithmic Method
7.3.1 World AI Drug Repurposing Platform Market Size by Algorithmic Method (2021-2026)
7.3.2 World AI Drug Repurposing Platform Market Size by Algorithmic Method (2027-2032)
7.3.3 World AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method (2027-2032)
8 MARKET ANALYSIS BY DELIVERY MODE
8.1 World AI Drug Repurposing Platform Market Size Overview by Delivery Mode: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Delivery Mode
8.2.1 SaaS Platform
8.2.2 Private Deployment
8.2.3 API and Data Service
8.2.4 Project-Based Collaboration
8.2.5 Platform with Wet-Lab Validation
8.3 Market Segment by Delivery Mode
8.3.1 World AI Drug Repurposing Platform Market Size by Delivery Mode (2021-2026)
8.3.2 World AI Drug Repurposing Platform Market Size by Delivery Mode (2027-2032)
8.3.3 World AI Drug Repurposing Platform Market Size Market Share by Delivery Mode (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World AI Drug Repurposing Platform Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Rare Disease Repurposing
9.2.2 Oncology Indication Expansion
9.2.3 Infectious Disease Response
9.2.4 CNS and Neurology Research
9.2.5 Immunology and Inflammation Research
9.2.6 Asset Rescue and Pipeline Optimization
9.3 Market Segment by Application
9.3.1 World AI Drug Repurposing Platform Market Size by Application (2021-2026)
9.3.2 World AI Drug Repurposing Platform Market Size by Application (2027-2032)
9.3.3 World AI Drug Repurposing Platform Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 BenevolentAI
10.1.1 BenevolentAI Details
10.1.2 BenevolentAI Major Business
10.1.3 BenevolentAI AI Drug Repurposing Platform Product and Services
10.1.4 BenevolentAI AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 BenevolentAI Recent Developments/Updates
10.1.6 BenevolentAI Competitive Strengths & Weaknesses
10.2 Healx
10.2.1 Healx Details
10.2.2 Healx Major Business
10.2.3 Healx AI Drug Repurposing Platform Product and Services
10.2.4 Healx AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Healx Recent Developments/Updates
10.2.6 Healx Competitive Strengths & Weaknesses
10.3 Insilico Medicine
10.3.1 Insilico Medicine Details
10.3.2 Insilico Medicine Major Business
10.3.3 Insilico Medicine AI Drug Repurposing Platform Product and Services
10.3.4 Insilico Medicine AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Insilico Medicine Recent Developments/Updates
10.3.6 Insilico Medicine Competitive Strengths & Weaknesses
10.4 Recursion
10.4.1 Recursion Details
10.4.2 Recursion Major Business
10.4.3 Recursion AI Drug Repurposing Platform Product and Services
10.4.4 Recursion AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Recursion Recent Developments/Updates
10.4.6 Recursion Competitive Strengths & Weaknesses
10.5 Lantern Pharma
10.5.1 Lantern Pharma Details
10.5.2 Lantern Pharma Major Business
10.5.3 Lantern Pharma AI Drug Repurposing Platform Product and Services
10.5.4 Lantern Pharma AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Lantern Pharma Recent Developments/Updates
10.5.6 Lantern Pharma Competitive Strengths & Weaknesses
10.6 SOM Biotech
10.6.1 SOM Biotech Details
10.6.2 SOM Biotech Major Business
10.6.3 SOM Biotech AI Drug Repurposing Platform Product and Services
10.6.4 SOM Biotech AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 SOM Biotech Recent Developments/Updates
10.6.6 SOM Biotech Competitive Strengths & Weaknesses
10.7 Standigm
10.7.1 Standigm Details
10.7.2 Standigm Major Business
10.7.3 Standigm AI Drug Repurposing Platform Product and Services
10.7.4 Standigm AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Standigm Recent Developments/Updates
10.7.6 Standigm Competitive Strengths & Weaknesses
10.8 Pharos iBio
10.8.1 Pharos iBio Details
10.8.2 Pharos iBio Major Business
10.8.3 Pharos iBio AI Drug Repurposing Platform Product and Services
10.8.4 Pharos iBio AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Pharos iBio Recent Developments/Updates
10.8.6 Pharos iBio Competitive Strengths & Weaknesses
10.9 Aitia
10.9.1 Aitia Details
10.9.2 Aitia Major Business
10.9.3 Aitia AI Drug Repurposing Platform Product and Services
10.9.4 Aitia AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 Aitia Recent Developments/Updates
10.9.6 Aitia Competitive Strengths & Weaknesses
10.10 Causaly
10.10.1 Causaly Details
10.10.2 Causaly Major Business
10.10.3 Causaly AI Drug Repurposing Platform Product and Services
10.10.4 Causaly AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Causaly Recent Developments/Updates
10.10.6 Causaly Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 AI Drug Repurposing Platform Industry Chain
11.2 AI Drug Repurposing Platform Upstream Analysis
11.3 AI Drug Repurposing Platform Midstream Analysis
11.4 AI Drug Repurposing Platform Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 AI Drug Repurposing Platform Introduction
1.2 World AI Drug Repurposing Platform Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Drug Repurposing Platform Total Market by Region (by Headquarter Location)
1.3.1 World AI Drug Repurposing Platform Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.3 China Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.4 Europe Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.5 Japan Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.6 South Korea Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.3.8 India Based Company AI Drug Repurposing Platform Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Drug Repurposing Platform Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Drug Repurposing Platform Consumption Value (2021-2032)
2.2 World AI Drug Repurposing Platform Consumption Value by Region
2.2.1 World AI Drug Repurposing Platform Consumption Value by Region (2021-2026)
2.2.2 World AI Drug Repurposing Platform Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Drug Repurposing Platform Consumption Value (2021-2032)
2.4 China AI Drug Repurposing Platform Consumption Value (2021-2032)
2.5 Europe AI Drug Repurposing Platform Consumption Value (2021-2032)
2.6 Japan AI Drug Repurposing Platform Consumption Value (2021-2032)
2.7 South Korea AI Drug Repurposing Platform Consumption Value (2021-2032)
2.8 ASEAN AI Drug Repurposing Platform Consumption Value (2021-2032)
2.9 India AI Drug Repurposing Platform Consumption Value (2021-2032)
3 WORLD AI DRUG REPURPOSING PLATFORM COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Drug Repurposing Platform Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Drug Repurposing Platform Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Drug Repurposing Platform in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Drug Repurposing Platform in 2025
3.3 AI Drug Repurposing Platform Company Evaluation Quadrant
3.4 AI Drug Repurposing Platform Market: Overall Company Footprint Analysis
3.4.1 AI Drug Repurposing Platform Market: Region Footprint
3.4.2 AI Drug Repurposing Platform Market: Company Product Type Footprint
3.4.3 AI Drug Repurposing Platform Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Drug Repurposing Platform Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Drug Repurposing Platform Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Drug Repurposing Platform Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Drug Repurposing Platform Consumption Value Comparison
4.2.1 United States VS China: AI Drug Repurposing Platform Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Drug Repurposing Platform Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Drug Repurposing Platform Companies and Market Share, 2021-2026
4.3.1 United States Based AI Drug Repurposing Platform Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Drug Repurposing Platform Revenue, (2021-2026)
4.4 China Based Companies AI Drug Repurposing Platform Revenue and Market Share, 2021-2026
4.4.1 China Based AI Drug Repurposing Platform Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Drug Repurposing Platform Revenue, (2021-2026)
4.5 Rest of World Based AI Drug Repurposing Platform Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Drug Repurposing Platform Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Drug Repurposing Platform Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Drug Repurposing Platform Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Target and Mechanism Mining
5.2.2 Drug?Disease Matching
5.2.3 Indication Expansion
5.2.4 Combination Therapy Prediction
5.2.5 Evidence Ranking and Validation
5.2.6 Safety and Translational Assessment
5.3 Market Segment by Type
5.3.1 World AI Drug Repurposing Platform Market Size by Type (2021-2026)
5.3.2 World AI Drug Repurposing Platform Market Size by Type (2027-2032)
5.3.3 World AI Drug Repurposing Platform Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DATA FOUNDATION
6.1 World AI Drug Repurposing Platform Market Size Overview by Data Foundation: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Data Foundation
6.2.1 Biomedical Knowledge Graphs
6.2.2 Multi-Omics Data
6.2.3 Clinical and Real-World Data
6.2.4 Literature and Patent Data
6.2.5 Chemical and Target Interaction Data
6.2.6 Integrated Multimodal Data
6.3 Market Segment by Data Foundation
6.3.1 World AI Drug Repurposing Platform Market Size by Data Foundation (2021-2026)
6.3.2 World AI Drug Repurposing Platform Market Size by Data Foundation (2027-2032)
6.3.3 World AI Drug Repurposing Platform Market Size Market Share by Data Foundation (2027-2032)
7 MARKET ANALYSIS BY ALGORITHMIC METHOD
7.1 World AI Drug Repurposing Platform Market Size Overview by Algorithmic Method: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Algorithmic Method
7.2.1 Knowledge Graph Reasoning
7.2.2 Machine Learning Prediction
7.2.3 Network Medicine Analysis
7.2.4 Causal Inference Modeling
7.2.5 Generative and Language Models
7.2.6 Hybrid Expert-in-the-Loop Models
7.3 Market Segment by Algorithmic Method
7.3.1 World AI Drug Repurposing Platform Market Size by Algorithmic Method (2021-2026)
7.3.2 World AI Drug Repurposing Platform Market Size by Algorithmic Method (2027-2032)
7.3.3 World AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method (2027-2032)
8 MARKET ANALYSIS BY DELIVERY MODE
8.1 World AI Drug Repurposing Platform Market Size Overview by Delivery Mode: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Delivery Mode
8.2.1 SaaS Platform
8.2.2 Private Deployment
8.2.3 API and Data Service
8.2.4 Project-Based Collaboration
8.2.5 Platform with Wet-Lab Validation
8.3 Market Segment by Delivery Mode
8.3.1 World AI Drug Repurposing Platform Market Size by Delivery Mode (2021-2026)
8.3.2 World AI Drug Repurposing Platform Market Size by Delivery Mode (2027-2032)
8.3.3 World AI Drug Repurposing Platform Market Size Market Share by Delivery Mode (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World AI Drug Repurposing Platform Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Rare Disease Repurposing
9.2.2 Oncology Indication Expansion
9.2.3 Infectious Disease Response
9.2.4 CNS and Neurology Research
9.2.5 Immunology and Inflammation Research
9.2.6 Asset Rescue and Pipeline Optimization
9.3 Market Segment by Application
9.3.1 World AI Drug Repurposing Platform Market Size by Application (2021-2026)
9.3.2 World AI Drug Repurposing Platform Market Size by Application (2027-2032)
9.3.3 World AI Drug Repurposing Platform Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 BenevolentAI
10.1.1 BenevolentAI Details
10.1.2 BenevolentAI Major Business
10.1.3 BenevolentAI AI Drug Repurposing Platform Product and Services
10.1.4 BenevolentAI AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 BenevolentAI Recent Developments/Updates
10.1.6 BenevolentAI Competitive Strengths & Weaknesses
10.2 Healx
10.2.1 Healx Details
10.2.2 Healx Major Business
10.2.3 Healx AI Drug Repurposing Platform Product and Services
10.2.4 Healx AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Healx Recent Developments/Updates
10.2.6 Healx Competitive Strengths & Weaknesses
10.3 Insilico Medicine
10.3.1 Insilico Medicine Details
10.3.2 Insilico Medicine Major Business
10.3.3 Insilico Medicine AI Drug Repurposing Platform Product and Services
10.3.4 Insilico Medicine AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Insilico Medicine Recent Developments/Updates
10.3.6 Insilico Medicine Competitive Strengths & Weaknesses
10.4 Recursion
10.4.1 Recursion Details
10.4.2 Recursion Major Business
10.4.3 Recursion AI Drug Repurposing Platform Product and Services
10.4.4 Recursion AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Recursion Recent Developments/Updates
10.4.6 Recursion Competitive Strengths & Weaknesses
10.5 Lantern Pharma
10.5.1 Lantern Pharma Details
10.5.2 Lantern Pharma Major Business
10.5.3 Lantern Pharma AI Drug Repurposing Platform Product and Services
10.5.4 Lantern Pharma AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Lantern Pharma Recent Developments/Updates
10.5.6 Lantern Pharma Competitive Strengths & Weaknesses
10.6 SOM Biotech
10.6.1 SOM Biotech Details
10.6.2 SOM Biotech Major Business
10.6.3 SOM Biotech AI Drug Repurposing Platform Product and Services
10.6.4 SOM Biotech AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 SOM Biotech Recent Developments/Updates
10.6.6 SOM Biotech Competitive Strengths & Weaknesses
10.7 Standigm
10.7.1 Standigm Details
10.7.2 Standigm Major Business
10.7.3 Standigm AI Drug Repurposing Platform Product and Services
10.7.4 Standigm AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Standigm Recent Developments/Updates
10.7.6 Standigm Competitive Strengths & Weaknesses
10.8 Pharos iBio
10.8.1 Pharos iBio Details
10.8.2 Pharos iBio Major Business
10.8.3 Pharos iBio AI Drug Repurposing Platform Product and Services
10.8.4 Pharos iBio AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Pharos iBio Recent Developments/Updates
10.8.6 Pharos iBio Competitive Strengths & Weaknesses
10.9 Aitia
10.9.1 Aitia Details
10.9.2 Aitia Major Business
10.9.3 Aitia AI Drug Repurposing Platform Product and Services
10.9.4 Aitia AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 Aitia Recent Developments/Updates
10.9.6 Aitia Competitive Strengths & Weaknesses
10.10 Causaly
10.10.1 Causaly Details
10.10.2 Causaly Major Business
10.10.3 Causaly AI Drug Repurposing Platform Product and Services
10.10.4 Causaly AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Causaly Recent Developments/Updates
10.10.6 Causaly Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 AI Drug Repurposing Platform Industry Chain
11.2 AI Drug Repurposing Platform Upstream Analysis
11.3 AI Drug Repurposing Platform Midstream Analysis
11.4 AI Drug Repurposing Platform Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World AI Drug Repurposing Platform Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Drug Repurposing Platform Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Drug Repurposing Platform Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Drug Repurposing Platform Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Drug Repurposing Platform Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Drug Repurposing Platform Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Drug Repurposing Platform Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Drug Repurposing Platform Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Drug Repurposing Platform Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Drug Repurposing Platform Players in 2025
Table 12. World AI Drug Repurposing Platform Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Drug Repurposing Platform Company Evaluation Quadrant
Table 14. Head Office of Key AI Drug Repurposing Platform Players
Table 15. AI Drug Repurposing Platform Market: Company Product Type Footprint
Table 16. AI Drug Repurposing Platform Market: Company Product Application Footprint
Table 17. AI Drug Repurposing Platform Mergers & Acquisitions Activity
Table 18. United States VS China AI Drug Repurposing Platform Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Drug Repurposing Platform Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Drug Repurposing Platform Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Drug Repurposing Platform Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Drug Repurposing Platform Revenue Market Share (2021-2026)
Table 23. China Based AI Drug Repurposing Platform Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Drug Repurposing Platform Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Drug Repurposing Platform Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Drug Repurposing Platform Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Drug Repurposing Platform Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Drug Repurposing Platform Revenue Market Share (2021-2026)
Table 29. World AI Drug Repurposing Platform Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Drug Repurposing Platform Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Drug Repurposing Platform Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Drug Repurposing Platform Market Size by Data Foundation, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Drug Repurposing Platform Market Size Value by Data Foundation (2021-2026) & (USD Million)
Table 34. World AI Drug Repurposing Platform Market Size by Data Foundation (2027-2032) & (USD Million)
Table 35. World AI Drug Repurposing Platform Market Size by Algorithmic Method, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Drug Repurposing Platform Market Size Value by Algorithmic Method (2021-2026) & (USD Million)
Table 37. World AI Drug Repurposing Platform Market Size by Algorithmic Method (2027-2032) & (USD Million)
Table 38. World AI Drug Repurposing Platform Market Size by Delivery Mode, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Drug Repurposing Platform Market Size Value by Delivery Mode (2021-2026) & (USD Million)
Table 40. World AI Drug Repurposing Platform Market Size by Delivery Mode (2027-2032) & (USD Million)
Table 41. World AI Drug Repurposing Platform Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World AI Drug Repurposing Platform Market Size by Application (2021-2026) & (USD Million)
Table 43. World AI Drug Repurposing Platform Market Size by Application (2027-2032) & (USD Million)
Table 44. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 45. BenevolentAI Major Business
Table 46. BenevolentAI AI Drug Repurposing Platform Product and Services
Table 47. BenevolentAI AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. BenevolentAI Recent Developments/Updates
Table 49. BenevolentAI Competitive Strengths & Weaknesses
Table 50. Healx Basic Information, Manufacturing Base and Competitors
Table 51. Healx Major Business
Table 52. Healx AI Drug Repurposing Platform Product and Services
Table 53. Healx AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Healx Recent Developments/Updates
Table 55. Healx Competitive Strengths & Weaknesses
Table 56. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 57. Insilico Medicine Major Business
Table 58. Insilico Medicine AI Drug Repurposing Platform Product and Services
Table 59. Insilico Medicine AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Insilico Medicine Recent Developments/Updates
Table 61. Insilico Medicine Competitive Strengths & Weaknesses
Table 62. Recursion Basic Information, Manufacturing Base and Competitors
Table 63. Recursion Major Business
Table 64. Recursion AI Drug Repurposing Platform Product and Services
Table 65. Recursion AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Recursion Recent Developments/Updates
Table 67. Recursion Competitive Strengths & Weaknesses
Table 68. Lantern Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Lantern Pharma Major Business
Table 70. Lantern Pharma AI Drug Repurposing Platform Product and Services
Table 71. Lantern Pharma AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Lantern Pharma Recent Developments/Updates
Table 73. Lantern Pharma Competitive Strengths & Weaknesses
Table 74. SOM Biotech Basic Information, Manufacturing Base and Competitors
Table 75. SOM Biotech Major Business
Table 76. SOM Biotech AI Drug Repurposing Platform Product and Services
Table 77. SOM Biotech AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. SOM Biotech Recent Developments/Updates
Table 79. SOM Biotech Competitive Strengths & Weaknesses
Table 80. Standigm Basic Information, Manufacturing Base and Competitors
Table 81. Standigm Major Business
Table 82. Standigm AI Drug Repurposing Platform Product and Services
Table 83. Standigm AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Standigm Recent Developments/Updates
Table 85. Standigm Competitive Strengths & Weaknesses
Table 86. Pharos iBio Basic Information, Manufacturing Base and Competitors
Table 87. Pharos iBio Major Business
Table 88. Pharos iBio AI Drug Repurposing Platform Product and Services
Table 89. Pharos iBio AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Pharos iBio Recent Developments/Updates
Table 91. Pharos iBio Competitive Strengths & Weaknesses
Table 92. Aitia Basic Information, Manufacturing Base and Competitors
Table 93. Aitia Major Business
Table 94. Aitia AI Drug Repurposing Platform Product and Services
Table 95. Aitia AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Aitia Recent Developments/Updates
Table 97. Aitia Competitive Strengths & Weaknesses
Table 98. Causaly Basic Information, Manufacturing Base and Competitors
Table 99. Causaly Major Business
Table 100. Causaly AI Drug Repurposing Platform Product and Services
Table 101. Causaly AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Causaly Recent Developments/Updates
Table 103. Causaly Competitive Strengths & Weaknesses
Table 104. Global Key Players of AI Drug Repurposing Platform Upstream (Raw Materials)
Table 105. Global AI Drug Repurposing Platform Typical Customers
Table 1. World AI Drug Repurposing Platform Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Drug Repurposing Platform Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Drug Repurposing Platform Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Drug Repurposing Platform Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Drug Repurposing Platform Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Drug Repurposing Platform Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Drug Repurposing Platform Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Drug Repurposing Platform Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Drug Repurposing Platform Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Drug Repurposing Platform Players in 2025
Table 12. World AI Drug Repurposing Platform Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Drug Repurposing Platform Company Evaluation Quadrant
Table 14. Head Office of Key AI Drug Repurposing Platform Players
Table 15. AI Drug Repurposing Platform Market: Company Product Type Footprint
Table 16. AI Drug Repurposing Platform Market: Company Product Application Footprint
Table 17. AI Drug Repurposing Platform Mergers & Acquisitions Activity
Table 18. United States VS China AI Drug Repurposing Platform Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Drug Repurposing Platform Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Drug Repurposing Platform Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Drug Repurposing Platform Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Drug Repurposing Platform Revenue Market Share (2021-2026)
Table 23. China Based AI Drug Repurposing Platform Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Drug Repurposing Platform Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Drug Repurposing Platform Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Drug Repurposing Platform Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Drug Repurposing Platform Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Drug Repurposing Platform Revenue Market Share (2021-2026)
Table 29. World AI Drug Repurposing Platform Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Drug Repurposing Platform Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Drug Repurposing Platform Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Drug Repurposing Platform Market Size by Data Foundation, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Drug Repurposing Platform Market Size Value by Data Foundation (2021-2026) & (USD Million)
Table 34. World AI Drug Repurposing Platform Market Size by Data Foundation (2027-2032) & (USD Million)
Table 35. World AI Drug Repurposing Platform Market Size by Algorithmic Method, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Drug Repurposing Platform Market Size Value by Algorithmic Method (2021-2026) & (USD Million)
Table 37. World AI Drug Repurposing Platform Market Size by Algorithmic Method (2027-2032) & (USD Million)
Table 38. World AI Drug Repurposing Platform Market Size by Delivery Mode, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Drug Repurposing Platform Market Size Value by Delivery Mode (2021-2026) & (USD Million)
Table 40. World AI Drug Repurposing Platform Market Size by Delivery Mode (2027-2032) & (USD Million)
Table 41. World AI Drug Repurposing Platform Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World AI Drug Repurposing Platform Market Size by Application (2021-2026) & (USD Million)
Table 43. World AI Drug Repurposing Platform Market Size by Application (2027-2032) & (USD Million)
Table 44. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 45. BenevolentAI Major Business
Table 46. BenevolentAI AI Drug Repurposing Platform Product and Services
Table 47. BenevolentAI AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. BenevolentAI Recent Developments/Updates
Table 49. BenevolentAI Competitive Strengths & Weaknesses
Table 50. Healx Basic Information, Manufacturing Base and Competitors
Table 51. Healx Major Business
Table 52. Healx AI Drug Repurposing Platform Product and Services
Table 53. Healx AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Healx Recent Developments/Updates
Table 55. Healx Competitive Strengths & Weaknesses
Table 56. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 57. Insilico Medicine Major Business
Table 58. Insilico Medicine AI Drug Repurposing Platform Product and Services
Table 59. Insilico Medicine AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Insilico Medicine Recent Developments/Updates
Table 61. Insilico Medicine Competitive Strengths & Weaknesses
Table 62. Recursion Basic Information, Manufacturing Base and Competitors
Table 63. Recursion Major Business
Table 64. Recursion AI Drug Repurposing Platform Product and Services
Table 65. Recursion AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Recursion Recent Developments/Updates
Table 67. Recursion Competitive Strengths & Weaknesses
Table 68. Lantern Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Lantern Pharma Major Business
Table 70. Lantern Pharma AI Drug Repurposing Platform Product and Services
Table 71. Lantern Pharma AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Lantern Pharma Recent Developments/Updates
Table 73. Lantern Pharma Competitive Strengths & Weaknesses
Table 74. SOM Biotech Basic Information, Manufacturing Base and Competitors
Table 75. SOM Biotech Major Business
Table 76. SOM Biotech AI Drug Repurposing Platform Product and Services
Table 77. SOM Biotech AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. SOM Biotech Recent Developments/Updates
Table 79. SOM Biotech Competitive Strengths & Weaknesses
Table 80. Standigm Basic Information, Manufacturing Base and Competitors
Table 81. Standigm Major Business
Table 82. Standigm AI Drug Repurposing Platform Product and Services
Table 83. Standigm AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Standigm Recent Developments/Updates
Table 85. Standigm Competitive Strengths & Weaknesses
Table 86. Pharos iBio Basic Information, Manufacturing Base and Competitors
Table 87. Pharos iBio Major Business
Table 88. Pharos iBio AI Drug Repurposing Platform Product and Services
Table 89. Pharos iBio AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Pharos iBio Recent Developments/Updates
Table 91. Pharos iBio Competitive Strengths & Weaknesses
Table 92. Aitia Basic Information, Manufacturing Base and Competitors
Table 93. Aitia Major Business
Table 94. Aitia AI Drug Repurposing Platform Product and Services
Table 95. Aitia AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Aitia Recent Developments/Updates
Table 97. Aitia Competitive Strengths & Weaknesses
Table 98. Causaly Basic Information, Manufacturing Base and Competitors
Table 99. Causaly Major Business
Table 100. Causaly AI Drug Repurposing Platform Product and Services
Table 101. Causaly AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Causaly Recent Developments/Updates
Table 103. Causaly Competitive Strengths & Weaknesses
Table 104. Global Key Players of AI Drug Repurposing Platform Upstream (Raw Materials)
Table 105. Global AI Drug Repurposing Platform Typical Customers
LIST OF FIGURES
Figure 1. AI Drug Repurposing Platform Picture
Figure 2. World AI Drug Repurposing Platform Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Drug Repurposing Platform Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Drug Repurposing Platform Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Drug Repurposing Platform Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 13. AI Drug Repurposing Platform Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Drug Repurposing Platform Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Drug Repurposing Platform by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Drug Repurposing Platform Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Drug Repurposing Platform Markets in 2025
Figure 27. United States VS China: AI Drug Repurposing Platform Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Drug Repurposing Platform Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Drug Repurposing Platform Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Drug Repurposing Platform Market Size Market Share by Type in 2025
Figure 31. Target and Mechanism Mining
Figure 32. Drug?Disease Matching
Figure 33. Indication Expansion
Figure 34. Combination Therapy Prediction
Figure 35. Evidence Ranking and Validation
Figure 36. Safety and Translational Assessment
Figure 37. World AI Drug Repurposing Platform Market Size Market Share by Type (2021-2032)
Figure 38. World AI Drug Repurposing Platform Market Size by Data Foundation, (USD Million), 2021 & 2025 & 2032
Figure 39. World AI Drug Repurposing Platform Market Size Market Share by Data Foundation in 2025
Figure 40. Biomedical Knowledge Graphs
Figure 41. Multi-Omics Data
Figure 42. Clinical and Real-World Data
Figure 43. Literature and Patent Data
Figure 44. Chemical and Target Interaction Data
Figure 45. Integrated Multimodal Data
Figure 46. World AI Drug Repurposing Platform Market Size Market Share by Data Foundation (2021-2032)
Figure 47. World AI Drug Repurposing Platform Market Size by Algorithmic Method, (USD Million), 2021 & 2025 & 2032
Figure 48. World AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method in 2025
Figure 49. Knowledge Graph Reasoning
Figure 50. Machine Learning Prediction
Figure 51. Network Medicine Analysis
Figure 52. Causal Inference Modeling
Figure 53. Generative and Language Models
Figure 54. Hybrid Expert-in-the-Loop Models
Figure 55. World AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method (2021-2032)
Figure 56. World AI Drug Repurposing Platform Market Size by Delivery Mode, (USD Million), 2021 & 2025 & 2032
Figure 57. World AI Drug Repurposing Platform Market Size Market Share by Delivery Mode in 2025
Figure 58. SaaS Platform
Figure 59. Private Deployment
Figure 60. API and Data Service
Figure 61. Project-Based Collaboration
Figure 62. Platform with Wet-Lab Validation
Figure 63. World AI Drug Repurposing Platform Market Size Market Share by Delivery Mode (2021-2032)
Figure 64. World AI Drug Repurposing Platform Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 65. World AI Drug Repurposing Platform Market Size Market Share by Application in 2025
Figure 66. Rare Disease Repurposing
Figure 67. Oncology Indication Expansion
Figure 68. Infectious Disease Response
Figure 69. CNS and Neurology Research
Figure 70. Immunology and Inflammation Research
Figure 71. Asset Rescue and Pipeline Optimization
Figure 72. World AI Drug Repurposing Platform Market Size Market Share by Application (2021-2032)
Figure 73. AI Drug Repurposing Platform Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. AI Drug Repurposing Platform Picture
Figure 2. World AI Drug Repurposing Platform Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Drug Repurposing Platform Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Drug Repurposing Platform Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Drug Repurposing Platform Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Drug Repurposing Platform Revenue (2021-2032) & (USD Million)
Figure 13. AI Drug Repurposing Platform Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Drug Repurposing Platform Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Drug Repurposing Platform by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Drug Repurposing Platform Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Drug Repurposing Platform Markets in 2025
Figure 27. United States VS China: AI Drug Repurposing Platform Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Drug Repurposing Platform Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Drug Repurposing Platform Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Drug Repurposing Platform Market Size Market Share by Type in 2025
Figure 31. Target and Mechanism Mining
Figure 32. Drug?Disease Matching
Figure 33. Indication Expansion
Figure 34. Combination Therapy Prediction
Figure 35. Evidence Ranking and Validation
Figure 36. Safety and Translational Assessment
Figure 37. World AI Drug Repurposing Platform Market Size Market Share by Type (2021-2032)
Figure 38. World AI Drug Repurposing Platform Market Size by Data Foundation, (USD Million), 2021 & 2025 & 2032
Figure 39. World AI Drug Repurposing Platform Market Size Market Share by Data Foundation in 2025
Figure 40. Biomedical Knowledge Graphs
Figure 41. Multi-Omics Data
Figure 42. Clinical and Real-World Data
Figure 43. Literature and Patent Data
Figure 44. Chemical and Target Interaction Data
Figure 45. Integrated Multimodal Data
Figure 46. World AI Drug Repurposing Platform Market Size Market Share by Data Foundation (2021-2032)
Figure 47. World AI Drug Repurposing Platform Market Size by Algorithmic Method, (USD Million), 2021 & 2025 & 2032
Figure 48. World AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method in 2025
Figure 49. Knowledge Graph Reasoning
Figure 50. Machine Learning Prediction
Figure 51. Network Medicine Analysis
Figure 52. Causal Inference Modeling
Figure 53. Generative and Language Models
Figure 54. Hybrid Expert-in-the-Loop Models
Figure 55. World AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method (2021-2032)
Figure 56. World AI Drug Repurposing Platform Market Size by Delivery Mode, (USD Million), 2021 & 2025 & 2032
Figure 57. World AI Drug Repurposing Platform Market Size Market Share by Delivery Mode in 2025
Figure 58. SaaS Platform
Figure 59. Private Deployment
Figure 60. API and Data Service
Figure 61. Project-Based Collaboration
Figure 62. Platform with Wet-Lab Validation
Figure 63. World AI Drug Repurposing Platform Market Size Market Share by Delivery Mode (2021-2032)
Figure 64. World AI Drug Repurposing Platform Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 65. World AI Drug Repurposing Platform Market Size Market Share by Application in 2025
Figure 66. Rare Disease Repurposing
Figure 67. Oncology Indication Expansion
Figure 68. Infectious Disease Response
Figure 69. CNS and Neurology Research
Figure 70. Immunology and Inflammation Research
Figure 71. Asset Rescue and Pipeline Optimization
Figure 72. World AI Drug Repurposing Platform Market Size Market Share by Application (2021-2032)
Figure 73. AI Drug Repurposing Platform Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
